A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer-Reference-Cited by-同舟云学术

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer

Published:2023-07 Issue: Volume:33 Page:101670
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Lu Jianming^ORCID,Chen Jiahong,Lin Zhuoyuan^ORCID,Liu Qinwei,Zhong Chuanfan,Cai Zhouda,Jia Zhenyu^ORCID,Zhong Weide,Liang Yingke,Cai Chao^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2021

2. Surveillance Research Program NCI. SEER*explorer: an interactive website for SEER cancer statistics [Internet]. 2021 [Available from: https://seer.cancer.gov/explorer/.

3. National Cancer Institute D, surveillance research program, surveillance systems branch. Surveillance, epidemiology, and end results (SEER) program SEER*stat database: incidence – SEER 18 regs research data 2020 [updated April 2021. Available from: https://seer.cancer.gov/canques/survival.html.

4. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate Cancer;Cornford;Eur. Urol.,2021

5. Gene expression regulation mediated through reversible m⁶A RNA methylation;Fu;Nat. Rev. Genet.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From microscopes to molecules: The evolution of prostate cancer diagnostics;Cytojournal;2024-08-29

2. The m6A regulators in prostate cancer: molecular basis and clinical perspective;Frontiers in Pharmacology;2024-08-29

3. Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review);Oncology Reports;2024-05-13

4. The functions and mechanisms of RNA modification in prostate: Current status and future perspectives;Frontiers in Genetics;2024-05-10

5. N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer;Human Genetics;2023-09-27